Journal of Biosciences and Medicines

Journal of Biosciences and Medicines

ISSN Print: 2327-5081
ISSN Online: 2327-509X
www.scirp.org/journal/jbm
E-mail: jbm@scirp.org

Call For Papers

Special Issue on

Biomedical, Biopharma and Clinical Research

 

Biomedical, biopharma, and clinical research are related fields that involve the study of biological and medical processes, with a focus on developing new treatments and therapies for human diseases. The goal of this special issue is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in the area of Biomedical, Biopharma and Clinical Research.

 

In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on exploring Biomedical, Biopharma and Clinical Research. Potential topics include, but are not limited to:


  • Drug development
  • Precision medicine
  • Pharmacology
  • Pharmaceuticals
  • Biologics
  • Biomarkers
  • Pharmacogenomics
  • Drug delivery
  • Clinical operations
  • Clinical research coordination
  • Medical writing
  • Quality assurance
  • Clinical supply chain management
  • Clinical data analysis
  • Patient recruitment
  • Biostatistics
  • Epidemiology
  • Safety and pharmacovigilance


Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.

 

Please kindly specify the “Special Issue” under your manuscript title. The research field “Special Issue - Biomedical, Biopharma and Clinical Research” should be selected during your submission.

 

Special Issue Timetable:

 

Submission Deadline

April 22nd, 2024

Publication Date

June 2024

 

Guest Editor: 

 

For further questions or inquiries, please contact Editorial Assistant at jbm@scirp.org.

Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top